C. Leitner

What's new in small cell lung cancer - extensive disease? An overview on advances of systemic treatment in 2016.

G. Spizzo, K. Philipp-Abbrederis, F. Kocher, 2017, Future oncology.

Progressive brain metastases in an EGFR mutated adenocarcinoma of the lung: Response to gefitinib after progression on erlotinib

R. Cathomas, M. Früh, M. Mark, 2014 .

Long-term life history predicts current gut microbiome in a population-based cohort study

H. Tilg, J. Raes, S. Kiechl, 2022, Nature Aging.

Improved survival of older patients with multiple myeloma in the era of novel agents

R. Cathomas, D. Klingbiel, C. Driessen, 2016, Hematological oncology.

Treatment of patients with refractory metastatic cancer according to molecular profiling on tumor tissue in the clinical routine: an interim-analysis of the ONCO-T-PROFILE project

K. Russell, H. Zwierzina, W. Eisterer, 2016, Genes & cancer.